Pennsylvania statute of limitations: 2 years from date of injury.. If you experienced GLP-1 side effects consult a legal professional about your specific deadline immediately.
Can Pennsylvania Residents File GLP-1 Lawsuits?
Yes. Pennsylvania residents who took GLP-1 medications including Ozempic, Wegovy, Mounjaro, Zepbound, or compounded semaglutide and suffered documented side effects are eligible to have their cases reviewed. Pennsylvania residents have strong product liability protections. Philadelphia and Pittsburgh both have active plaintiff bar communities handling pharmaceutical mass tort cases. All cases are filed in federal court as part of the Multi-District Litigation regardless of what state you live in.
Active Lawsuit Conditions for Pennsylvania Residents
- Gastroparesis or stomach paralysis requiring medical treatment - learn more about gastroparesis lawsuits
- NAION or sudden vision loss diagnosed by a physician - learn more about vision loss lawsuits
- Severe pancreatitis requiring hospitalization - learn more about pancreatitis lawsuits
- Gallbladder disease or emergency gallbladder removal - learn more about gallbladder lawsuits
- Any serious documented medical condition occurring during GLP-1 medication use
Where Do These Cases Stand in May 2026?
As of May 2026 over 12,000 cases have been filed in federal multidistrict litigation across two separate MDLs. A Science Day has been scheduled for June 2 2026. Bellwether trial selection is expected in late 2026. For full details see our monthly litigation timeline.
Does It Cost Anything?
No. Attorneys work on contingency - they only get paid when you receive compensation. The case review is completely free and takes approximately 5 to 10 minutes. A legal case specialist will contact you within 24 hours.
Check Your Eligibility - Free
90 seconds. No cost. No obligation. A specialist contacts you within 24 hours.